Inhaler training study aims to cut COPD errors

NCT ID NCT02813200

Completed Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well people with COPD can learn to use three different inhaler devices: Diskus, Breezhaler, and Respimat. Twenty-four participants were taught to use each device and then checked for mistakes. The goal is to find better ways to train patients so they get the full benefit of their medication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Seretide Diskus, Ultibro Breezhaler, Spiriva Respimat
What this could lead to: If successful, this could help doctors teach patients how to use inhalers correctly, leading to better symptom control and fewer hospital visits.
What could go wrong: This is a small, completed study (24 people) that only looks at learning ability, not long-term health outcomes. Results may not apply to all COPD patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Contacts and locations

Locations

CIC-P - Centre François Magendie - G3 - Hôpital Haut-Lévêque

Bordeaux, 33604, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.